Below are current clinical trials.3 studies in Gastrointestinal stromal tumors (GISTs)
(open studies only).
Filter this list of studies by location, status and more.
Information regarding the delay in diagnosis as well as the causes of the delay are lacking in the U.S. Specifically, we aim to identify patient factors and provider factors that contribute to delayed diagnosis of sarcoma.
The goal of this study is to create a comprehensive system of tissue banking of samples from Mayo Clinic Arizona patients with a clinical diagnosis of sarcoma who will or have undergone a surgical procedure to remove the sarcoma. The tissue samples will be used for future research of sarcoma at Mayo Clinic and future research at Mayo Clinic to learn about, prevent, or treat other health problems.
Jacksonville, Fla., Rochester, Minn.
The objective is to compare the efficacy and safety of masitinib at 12 mg/kg/day to sunitinib at 50 mg/day
Aug. 23, 2017
- AskMayoExpert. Gastrointestinal stromal tumor. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- Feldman M, et al. Gastrointestinal stromal tumors (GISTs). In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 10th ed. Philadelphia, Pa.: Saunders Elsevier; 2016. http://www.clinicalkey.com. Accessed April 15, 2016.
- Gastrointestinal stromal tumors treatment – Patient version (PDQ). National Cancer Institute. http://www.cancer.gov/types/soft-tissue-sarcoma/patient/gist-treatment-pdq. Accessed April 15, 2016.
- Soft tissue sarcoma. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed April 15, 2016.
Gastrointestinal stromal tumors (GISTs)